30.10.2012 • NewsAnadarkoBPBP oil spill

Anadarko Petroleum Has Quarterly Profit

Anadarko Petroleum on Monday reported a quarterly profit compared with a year-ago loss when the U.S. oil and gas company set aside funds to settle with BP over its Gulf of Mexico oil spill.

Anadarko had a third-quarter profit $121 million, or 24 cents per share, compared with a loss of $3.1 billion, or $6.12 per share in the comparable quarter a year earlier.

Excluding one-time items, Anadarko had a profit of 84 cents per share. Analysts on average had expected a profit of 76 cents per share, according to Thomson Reuters I/B/E/S.

The company's total sales of oil and gas rose to 68 million barrels oil equivalent (boe), from 61 million boe in the same quarter a year earlier.

Anadarko expects to produce 265 million boe to 267 million boe this year, higher than its second-quarter forecast for output of 261 million boe to 265 million boe.

The company, which will discuss earnings with analysts on Tuesday, also said it met with success drilling offshore Mozambique, where it has identified resources capable of supplying 50 million tons per year of liquefied natural gas.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.

Photo
27.03.2025 • News

Moeve Joins Global Impact Coalition

The Global Impact Coalition (GIC), a collaborative platform led by CEOs and focused on achieving a net-zero chemicals future, has announced the addition of Moeve as its newest member.